Artificial MicroRNAs as Novel Secreted Reporters for Cell Monitoring in Living Subjects

• Published in: PloS one Vol. 11; no. 7; p. e0159369
• Main Authors: Ronald, John A., D’Souza, Aloma L., Chuang, Hui-Yen, Gambhir, Sanjiv Sam
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 21.07.2016; Public Library of Science (PLoS)
• Subjects: Animals; Antigens; Bioindicators; Biology and life sciences; Bioluminescence; Biomarkers; Blood; Blood levels; Breast cancer; Cell culture; Cell number; Cell Tracking - methods; Cells; Cellular therapy; Culture media; Diagnostic systems; Genes; Genes, Reporter; Genetic aspects; HeLa Cells; Humans; Imaging; Imaging, Three-Dimensional; Implantation; In vitro methods and tests; Lung cancer; Media (culture); Medical imaging; Medical prognosis; Medicine and Health Sciences; Mice; MicroRNA; MicroRNAs; MicroRNAs - blood; MicroRNAs - metabolism; miRNA; Monitoring; mRNA; Multiplexing; NMR; Nuclear magnetic resonance; Patients; Pollution monitoring; Positron emission; Positron emission tomography; Proteins; Radiology; Reporter gene; Research and Analysis Methods; Ribonucleic acid; RNA; Secretion; Stem cells; Tomography; Transfection; Tumors; Ontario Canada; Canada; California; United States > US
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0159369

Reporter genes are powerful technologies that can be used to directly inform on the fate of transplanted cells in living subjects. Imaging reporter genes are often employed to quantify cell number, location(s), and viability with various imaging modalities. To complement this, reporters that are secreted from cells can provide a low-cost, in vitro diagnostic test to monitor overall cell viability at relatively high frequency without knowing the locations of all cells. Whereas protein-based secretable reporters have been developed, an RNA-based reporter detectable with amplification inherent PCR-based assays has not been previously described. MicroRNAs (miRNAs) are short non-coding RNAs (18-22 nt) that regulate mRNA translation and are being explored as relatively stable blood-based disease biomarkers. We developed an artificial miRNA-based secreted reporter, called Sec-miR, utilizing a coding sequence that is not expressed endogenously and does not have any known vertebrate target. Sec-miR was detectable in both the cells and culture media of transiently transfected cells. Cells stably expressing Sec-miR also reliably secreted it into the culture media. Mice implanted with parental HeLa cells or HeLa cells expressing both Sec-miR and the bioluminescence imaging (BLI) reporter gene Firefly luciferase (FLuc) were monitored over time for tumor volume, FLuc signal via BLI, and blood levels of Sec-miR. Significantly (p<0.05) higher Sec-miR was found in the blood of mice bearing Sec-miR-expressing tumors compared to parental cell tumors at 21 and 28 days after implantation. Importantly, blood Sec-miR reporter levels after day 21 showed a trend towards correlation with tumor volume (R2 = 0.6090; p = 0.0671) and significantly correlated with FLuc signal (R2 = 0.7067; p<0.05). Finally, we could significantly (p<0.01) amplify Sec-miR secretion into the cell media by chaining together multiple Sec-miR copies (4 instead of 1 or 2) within an expression cassette. Overall, we show that a novel complement of BLI together with a unique Sec-miR reporter adds an in vitro RNA-based diagnostic to enhance the monitoring of transplanted cells. While Sec-miR was not as sensitive as BLI for monitoring cell number, it may be more sensitive than clinically-relevant positron emission tomography (PET) reporter assays. Future work will focus on improving cell detectability via improved secretion of Sec-miR reporters from cells and more sensitive detection platforms, as well as, exploring other miRNA sequences to allow multiplexed monitoring of more than one cell population at a time. Continued development may lead to more refined and precise monitoring of cell-based therapies.